Install
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
- 94articles · 30d
- 1+ day agolatest article
- Aug 17, 2026earliest in window
- 95%with images
- 86avg words
- health 56
- business 43
- biotech 35
- fda 28
- pharma 28
- biotechnology 26
- cancer 21
- drug development 21
- clinical trials 19
- type-newspost 19
- tmt newswire 16
- globenewswire 15
- pharmaceuticals 15
- stat+ 15
- biopharma 13
- markets 13
- oncology 13
- (midwest communications 12
- artificial intelligence 12
- business & health 11
- Health & Wellness 74
- Medical 63
- Science & Technology 31
- Health 30
- Economy, Business & Finance 27
- Finance & Business 21
- Business & Industrial 15
- Science & Nature 7
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Encoded closes $275M Series F for Dravet syndrome drug
4+ day, 23+ hour ago (75+ words) Endpoints News Encoded closes $275M Series F for Dravet syndrome drug Encoded Therapeutics has tacked on $275 million in new capital, closing a Series F round led…...
NodThera, a decade-old NLRP3 player, plans Phase 3 and a rebrand
5+ day, 5+ hour ago (82+ words) Endpoints News NodThera, a decade-old NLRP3 player, plans Phase 3 and a rebrand After tinkering with the biology of the broadly appealing anti-inflammatory NLRP3 path…...
Beeline Medicines reports promising Phase 2 lupus data
5+ day, 5+ hour ago (81+ words) Beeline Medicines reports promising mid-stage lupus data Endpoints News Beeline Medicines reports promising mid-stage lupus data The business of advancing shelved pharma assets continues to reap…...
Exclusive: Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinic
5+ day, 5+ hour ago (92+ words) Endpoints News Exclusive: Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinic Pfizer and Merck KGaA’s venture groups are backing a nimble cancer startup tak…...
Kura Oncology spins out diabetes pipeline with $50M and Lilly's help
5+ day, 5+ hour ago (79+ words) Kura Oncology spins out diabetes pipeline with $50M and Lilly’s help Endpoints News Kura Oncology spins out diabetes pipeline with $50M and Lilly's help Kura Oncology, the maker of the…...
Moonwalk raises $70M to test siRNA treatment for obesity
6+ day, 4+ hour ago (75+ words) Endpoints News Moonwalk raises $70M to test siRNA treatment for obesity Moonwalk Biosciences is heading to the clinic with an obesity program and has raised $70 million for…...
Diabetes cell therapy biotechs Sernova and Seraxis to merge
6+ day, 5+ hour ago (79+ words) Endpoints News Diabetes cell therapy biotechs Sernova and Seraxis to merge Two companies that have spent decades trying to develop cell therapies for dia…...
AbbVie-allied ADARx aims to go public with 3 drugs in the clinic
1+ week, 2+ day ago (90+ words) Endpoints News AbbVie-allied ADARx aims to go public with 3 drugs in the clinic RNA interference company ADARx Pharmaceuticals revealed its intentions to go…...
Alumis falls after TYK2 pill fails lupus study, but CEO sees 'clear path forward"
1+ week, 6+ day ago (80+ words) Alumis falls after TYK2 pill fails lupus study, but CEO sees 'clear path forward' Endpoints News Alumis falls after TYK2 pill fails lupus study, but CEO sees 'clear path forward' Alumis’ lead drug program suffered…...
Roivant’s road to a potential blockbuster begins with Lisraya FDA approval
2+ week, 3+ day ago (86+ words) Endpoints News Roivant’s road to a potential blockbuster begins with Lisraya FDA approval The FDA approved Roivant’s dermatomyositis drug brepocitinib on Wednesday, the first major…...